Cell Technologies Intelligence
Track diseases, compounds, modalities, regulations and competitors. Click Run Intelligence to fetch the latest from ClinicalTrials.gov, PubMed and the open web in one cited briefing. Topics persist on this device and feed into Delfi and Oracle as context.
Both tools run entirely in your browser. Your API key and analysis history are stored locally — never on a server. Open either tool below to get started, or use the workflow at the bottom to see how they connect.
- Trial Design — 14-section protocol synopses with appended CMC Risk Register
- R&D Decision Report — 7-dimension GO/NO-GO with Path-to-Outcome panel
- Regulatory Pathway — IND strategy, expedited program eligibility
- Competitive Intelligence — landscape analysis and differentiation
- Market & Disease — therapeutic areas ranked by unmet need
- Multi-Modality Analysis — cell therapy vs biologics vs gene therapy vs small molecule
- Cell QC — release criteria for 7 cell types with RAG overlay
- Manufacturing Plan — full printable CMC plan + 8-10 risk cards
From disease to trial design in one session
Use Oracle to identify the right modality and design the manufacturing plan, then hand off to Delfi for the full clinical protocol synopsis. The handoff carries the disease, modality, mechanism, manufacturing summary, and QC criteria directly into Delfi's Trial Design generator — no copy-paste between tools.